U.S. Pharmaceuticals & Biotech Most Popular Stocks

Lattice Biologics

Market Cap: US$128.0

A biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide.

Isodiol International

Market Cap: US$128.0

Engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States.

Emerging World Pharma

Market Cap: US$119.0

Invests in generic based pharmaceutical companies manufacturing within developing nations.

HEALTHeUNIVERSE

Market Cap: US$117.0

Healtheuniverse, Inc., a biotechnology development company, engages in the research, development, and commercialization of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products.

VMS Rehab Systems

Market Cap: US$111.0

Engages in generic drug and home healthcare businesses.

RVL Pharmaceuticals

Market Cap: US$111.0

A specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary.

MJardin Group

Market Cap: US$90.0

Through its subsidiaries, cultivates, harvests, processes, and sells cannabis products in Canada and the United States.

RenovaCare

Market Cap: US$87.0

A development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications.

Alliance Growers

Market Cap: US$85.0

Engages in acquiring investments in and developing projects in the medical cannabis sector in British Columbia.

Gnomestar Craft

Market Cap: US$85.0

Engages in the production and distribution of cannabis product for medical and recreational use in Canada.

Chalice Brands

Market Cap: US$84.0

Engages in the retail, production, processing, wholesale, and distribution of cannabis products.

Winston Pharmaceuticals

Market Cap: US$77.0

Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management.

Indigenous Bloom Hemp

Market Cap: US$71.0

Focuses on the production of hemp products.

North Bud Farms

Market Cap: US$66.0

Through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada.

Capha Pharmaceuticals

Market Cap: US$64.0

Does not have significant operations.

Inyx

Market Cap: US$53.0

Through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe.

Panacos Pharmaceuticals

Market Cap: US$53.0

A development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases.

Baudax Bio

Market Cap: US$52.0

A pharmaceutical company, develops and commercializes products for hospital and other acute care related settings.

Orchid Ventures

Market Cap: US$52.0

Engages in the design, development, manufacturing, branding, and distribution of cannabis vape products in North America.

Optima Medical Innovations

Market Cap: US$47.0

Optima Medical Innovations Corp. delivers pathways to innovative, science-based health, and wellness solutions.

Callitas Health

Market Cap: US$45.0

Provides over the counter consumer health and wellness products in the United States and Canada.

Ember Therapeutics

Market Cap: US$43.0

Operates as a clinical stage biopharmaceutical company.

9342-8530 Québec

Market Cap: US$43.0

9342-8530 Québec Inc., a life sciences company, develops and commercializes products relating to the diagnosis of cancer in Canada.

US BioTec

Market Cap: US$41.0

Engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States.

Integrative Health Technologies

Market Cap: US$40.0

Provides fee-based clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries.

Response Genetics

Market Cap: US$38.0

A life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally.

Canntab Therapeutics

Market Cap: US$38.0

A phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada.

Miravant Medical Technologies

Market Cap: US$37.0

Operates as a pharmaceutical research and development company.

Claritas Pharmaceuticals

Market Cap: US$37.0

A clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs.

Synovics Pharmaceuticals

Market Cap: US$36.0

Through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States.

DermTech

Market Cap: US$35.0

A molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States.

ARYx Therapeutics

Market Cap: US$33.0

ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets.

Deltagen

Market Cap: US$32.0

Provides drug discovery tools and services to the biopharmaceutical industry.

Targeted Medical Pharma

Market Cap: US$29.0

A specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States.

Neurobiological Technologies

Market Cap: US$27.0

Operates under a plan of liquidation and dissolution approved by stockholders in October 2009.

Anthera Pharmaceuticals

Market Cap: US$26.0

A biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs.